Longeveron Inc.
(NASDAQ : LGVN)

( )
LGVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.37%283.400.0%$3951.53m
BNTXBioNTech SE -3.55%291.940.0%$1261.44m
NVAXNovavax, Inc. -0.60%181.7578.2%$864.57m
AMGNAmgen, Inc. 1.05%213.531.4%$651.58m
LGVNLongeveron Inc. 11.85%21.900.0%$515.31m
GILDGilead Sciences, Inc. 0.09%69.711.0%$515.13m
VRTXVertex Pharmaceuticals, Inc. 0.68%206.611.9%$454.10m
REGNRegeneron Pharmaceuticals, Inc. 2.98%654.042.7%$419.38m
ILMNIllumina, Inc. 1.77%375.983.3%$351.77m
SNSSSunesis Pharmaceuticals, Inc. 1.16%4.360.7%$304.78m
BIIBBiogen, Inc. 3.48%234.721.8%$297.97m
SGENSeagen Inc. 2.12%149.555.8%$157.99m
EXASEXACT Sciences Corp. 3.48%86.2618.0%$150.95m
INCYIncyte Corp. 0.90%67.332.4%$147.13m
BMRNBioMarin Pharmaceutical, Inc. 2.62%88.384.2%$138.75m

Company Profile

Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers in October 9, 2014 and is headquartered in Miami, FL.